RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BUTI S
Collezione AOU Alessandria

Items : 3

Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2026 Feb 3;75(3):66. doi: 10.1007/s00262-026-04318-x.

2026
AOU Alessandria

Maffezzoli M; Signori A; Acunzo A; Buti S; Bosoni M; Verzoni E; Di Marco A; Lolli C; Di Napoli M; Fanelli M; Volta AD; Masini C; Roviello G; Iacovelli R; Mennitto A; Filippi R; Sorarù M; Formisano L; Guida A; Fantinel E; Messina C; Bonomi L; Scagliarini S; Nasso C; Chiellino S; Maiorano BA; Deppieri F; Cavo A; Conteduca V; et alii...

Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication. in Journal of immunotherapy (Hagerstown, Md. : 1997) / J Immunother. 2023 Jan 1;46(1):22-26. doi: 10.1097/CJI.0000000000000446. Epub 2022 Nov 4.

2023
AOU Alessandria

Masini C; Chini C; Zai S; Nole' F; Mirabelli R; Hamzaj A; Favaretto A; Leo S; Baldini E; Zafarana E; Aschele C; Zucali PA; Cusmai A; Sabbatini R; Santoni M; Lo Re G; Fonarini G; Procopio G; Carrozza F; Porta C; Galli L; Iacovelli R; Maruzzo M; De Giorgi U; Giannarelli D; Buti S; Basso U; Fatigoni S; Rocchi A; et alii...

Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report. in Immunotherapy / Immunotherapy. 2022 Dec;14(18):1419-1427. doi: 10.2217/imt-2022-0150. Epub 2023 Jan 4.

2022
AOU Alessandria

Murianni V; Cerbone L; Rescigno P; Catalano F; Damassi A; Cremante M; Gandini A; Puglisi S; Pesola G; Banna GL; Buti S; Signori A; Fornarini G; Rebuzzi SE;